Review
doi: 10.1007/s00018-004-4257-y.The SARS-CoV S glycoprotein
Affiliations
- PMID:15526150
- PMCID: PMC7079772
- DOI: 10.1007/s00018-004-4257-y
Item in Clipboard
Review
The SARS-CoV S glycoprotein
X Xiao et al. Cell Mol Life Sci.2004 Oct.
Display options
Format
Display options
Format
Abstract
The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors.
Similar articles
- Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies.He Y.He Y.Adv Exp Med Biol. 2006;581:539-42. doi: 10.1007/978-0-387-33012-9_98.Adv Exp Med Biol. 2006.PMID:17037594Free PMC article.No abstract available.
- Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.Petit CM, Melancon JM, Chouljenko VN, Colgrove R, Farzan M, Knipe DM, Kousoulas KG.Petit CM, et al.Virology. 2005 Oct 25;341(2):215-30. doi: 10.1016/j.virol.2005.06.046. Epub 2005 Aug 15.Virology. 2005.PMID:16099010Free PMC article.
- Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.Madu IG, Roth SL, Belouzard S, Whittaker GR.Madu IG, et al.J Virol. 2009 Aug;83(15):7411-21. doi: 10.1128/JVI.00079-09. Epub 2009 May 13.J Virol. 2009.PMID:19439480Free PMC article.
- Insights from the association of SARS-CoV S-protein with its receptor, ACE2.Li W, Choe H, Farzan M.Li W, et al.Adv Exp Med Biol. 2006;581:209-18. doi: 10.1007/978-0-387-33012-9_36.Adv Exp Med Biol. 2006.PMID:17037532Free PMC article.Review.No abstract available.
- The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S.Du L, et al.Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9.Nat Rev Microbiol. 2009.PMID:19198616Free PMC article.Review.
Cited by
- The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2.Li W, Sui J, Huang IC, Kuhn JH, Radoshitzky SR, Marasco WA, Choe H, Farzan M.Li W, et al.Virology. 2007 Oct 25;367(2):367-74. doi: 10.1016/j.virol.2007.04.035. Epub 2007 Jul 12.Virology. 2007.PMID:17631932Free PMC article.
- Mapping immunological and host receptor binding determinants of SARS-CoV spike protein utilizing the Qubevirus platform.Sanders C, Dzelamonyuy A, Ntemafack A, Alatoom N, Nchinda G, Georgiadis MM, Bopda Waffo A.Sanders C, et al.J Biol Chem. 2023 Dec;299(12):105460. doi: 10.1016/j.jbc.2023.105460. Epub 2023 Nov 15.J Biol Chem. 2023.PMID:37977224Free PMC article.
- Viral glycoproteins: biological role and application in diagnosis.Banerjee N, Mukhopadhyay S.Banerjee N, et al.Virusdisease. 2016 Mar;27(1):1-11. doi: 10.1007/s13337-015-0293-5. Epub 2016 Jan 18.Virusdisease. 2016.PMID:26925438Free PMC article.Review.
- Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells.Thuy PX, Bao TDD, Moon EY.Thuy PX, et al.Biomed Pharmacother. 2022 Jun;150:113021. doi: 10.1016/j.biopha.2022.113021. Epub 2022 Apr 25.Biomed Pharmacother. 2022.PMID:35658221Free PMC article.
- Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein.Zhang SM, Liao Y, Neo TL, Lu Y, Liu DX, Vahlne A, Tam JP.Zhang SM, et al.Int J Biochem Cell Biol. 2018 Aug;101:103-112. doi: 10.1016/j.biocel.2018.05.012. Epub 2018 May 22.Int J Biochem Cell Biol. 2018.PMID:29800727Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Miscellaneous